Free Access
Issue |
Med Sci (Paris)
Volume 30, Number 4, Avril 2014
|
|
---|---|---|
Page(s) | 436 - 438 | |
Section | Microenvironnements tumoraux : conflictuels et complémentaires | |
DOI | https://doi.org/10.1051/medsci/20143004019 | |
Published online | 05 May 2014 |
- Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010 ; 10 : 159–169. [CrossRef] [PubMed] [Google Scholar]
- Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012 ; 491 : 254–258. [PubMed] [Google Scholar]
- Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009 ; 15 : 1016–1022. [CrossRef] [PubMed] [Google Scholar]
- Jobin C. Microbiome : un nouveau facteur de risque de cancer colorectal ? Med Sci (Paris) 2013 ; 29 : 582–585. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Ganal SC, Sanos SL, Kallfass C, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012 ; 37 : 171–186. [CrossRef] [PubMed] [Google Scholar]
- Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012 ; 37 : 158–170. [CrossRef] [PubMed] [Google Scholar]
- Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013 ; 342 : 967–970. [CrossRef] [PubMed] [Google Scholar]
- Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013 ; 342 : 971–976. [CrossRef] [PubMed] [Google Scholar]
- Fridman WH, Sautès-Fridman C. Le microenvironnement tumoral : matrice nourricière, champ de bataille et cible thérapeutique des cancers. Med Sci (Paris) 2014 ; 30 : 359–365. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bruchard M, Ghiringhelli F. Microenvironnement tumoral : cellules régulatrices et cytokines immunosuppressives. Med Sci (Paris) 2014 ; 30 : 429–435. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Galon J, Bindea G, Mlecnik B, et al. Microenvironnement immunitaire et cancer : intérêt de l’Immunoscore pour prédire l’évolution clinique. Med Sci (Paris) 2014 ; 30 : 439–444. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007 ; 13 : 1050–1059. [CrossRef] [PubMed] [Google Scholar]
- Shirota Y, Shirota H, Klinman DM. Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol 2012 ; 188 : 1592–1599. [CrossRef] [PubMed] [Google Scholar]
- Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 2005 ; 65 : 3437–3446. [PubMed] [Google Scholar]
- Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009 ; 15 : 1170–1178. [CrossRef] [PubMed] [Google Scholar]
- Viaud S, Flament C, Zoubir M, et al. Cyclophosphamide induces differentiation of Th17 cells in cancer patients. Cancer Res 2011 ; 71, 661–665. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.